Insights

AlphaSense Webinar Recap: AI For Investor Relations

AlphaSense's Kate Thunnissen and Chris Ackerson discuss augmented intelligence and its impact on Investor Relations workflows.

Read now
filter by
Healthcare

BIO CEO 2019: The Future Of IPOs And M&As In Biotech

Amy Onorato

At the BIO CEO & Investor Conference 2019, AlphaSense discusses the shifting M&A landscape following a record-setting year of biotech IPOs.

Read post
{{ post.topic }}
{{ post.date }}

{{ post.title }}

{{ post.author.name }} {{ post.author.title }}

{{ post.intro }}

Read post

Schedule a demo

To see AlphaSense in action, please fill out the form.

×